Zimmer, Biomet Sell Off Some U.S. Assets As They Finalize A $14 Bil. Merger

Zimmer Biomet is now the second-largest orthopedic device maker behind Johnson & Johnson now that the merger between the two firms is complete. The companies divested some U.S. knee, elbow and bone cement assets in conjunction with finalized the deal after having sold of some European assets earlier in the year.

Zimmer Biomet Holdings Inc. is Zimmer Biomet Holdings, Inc. now that it has acquired Biomet Inc., for about $14 billion in cash and stock, the company announced June 25. In addition, the firms signed off on the last product divestitures needed to close the deal.

The combined company will trade on the New York Stock Exchange and the SIX Swiss Exchange under the symbol ZBH,...

More from Archive

More from Medtech Insight